Suppr超能文献

经非常规途径给药的药物的毒理学评估:鼻内、眼内、鞘内/脊髓内和关节内给药。

Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.

作者信息

Emami Armaghan, Tepper Jeff, Short Brian, Yaksh Tony L, Bendele Alison M, Ramani Thulasi, Cisternas Alvaro F, Chang Jay H, Mellon R Daniel

机构信息

1 US Food and Drug Administration, Silver Spring, MD, USA.

2 Tepper Nonclinical Consulting, San Carlos, CA, USA.

出版信息

Int J Toxicol. 2018 Jan/Feb;37(1):4-27. doi: 10.1177/1091581817741840. Epub 2017 Dec 21.

Abstract

As the need for nasal, ocular, spinal, and articular therapeutic compounds increases, toxicology assessments of drugs administered via these routes play an important role in human safety. This symposium outlined the local and systemic evaluation to support safety during the development of these drugs in nonclinical models with some case studies. Discussions included selection of appropriate species for the intended route; conducting nonclinical studies that closely mimic the intended use with adequate duration; functional assessment, if deemed necessary; evaluation of local tissues with special histological staining procedure; and evaluations of safety margins based on local and systemic toxicity.

摘要

随着对鼻腔、眼部、脊柱和关节治疗化合物需求的增加,通过这些途径给药的药物毒理学评估在人类安全方面发挥着重要作用。本次研讨会概述了在非临床模型中开发这些药物时支持安全性的局部和全身评估,并列举了一些案例研究。讨论内容包括为预期给药途径选择合适的物种;进行能紧密模拟预期用途且持续时间足够的非临床研究;如有必要进行功能评估;采用特殊组织学染色程序评估局部组织;以及基于局部和全身毒性评估安全边际。

相似文献

2
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
Int J Toxicol. 2007 Sep-Oct;26(5):411-21. doi: 10.1080/10915810701582970.
3
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Eur J Pharm Biopharm. 2014 Sep;88(1):8-27. doi: 10.1016/j.ejpb.2014.03.004. Epub 2014 Mar 28.
4
General considerations in ocular toxicity risk assessment from the toxicologists' viewpoints.
J Toxicol Sci. 2015 Jun;40(3):295-307. doi: 10.2131/jts.40.295.
6
Nasal and buccal drug delivery: management forum conference.
Ther Deliv. 2012 Jul;3(7):819-22. doi: 10.4155/tde.12.60.
7
Giving intrathecal drugs.
Am J Nurs. 1986 Jul;86(7):829-31.
8
Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective.
Regul Toxicol Pharmacol. 2020 Nov;117:104746. doi: 10.1016/j.yrtph.2020.104746. Epub 2020 Sep 8.
9
Intrathecal therapy for cancer and non-cancer pain.
Pain Physician. 2011 May-Jun;14(3):219-48.

引用本文的文献

2
A Brief Review of Drugs and Supplements Testing in Induced Osteoarthritis Murine Models: Methodologies and Findings.
Curr Health Sci J. 2024 Oct-Dec;50(4):467-477. doi: 10.12865/CHSJ.50.04.01. Epub 2024 Dec 31.
5
Edge advances in nanodrug therapies for osteoarthritis treatment.
Front Pharmacol. 2024 Oct 30;15:1402825. doi: 10.3389/fphar.2024.1402825. eCollection 2024.
6
Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product.
Ophthalmol Ther. 2025 Jan;14(1):85-101. doi: 10.1007/s40123-024-01043-5. Epub 2024 Nov 6.
7
Progress and Challenges of Topical Delivery Technologies Meditated Drug Therapy for Osteoarthritis.
Int J Nanomedicine. 2024 Aug 14;19:8337-8352. doi: 10.2147/IJN.S466437. eCollection 2024.
8
Unraveling the path to osteoarthritis management: targeting chondrocyte apoptosis for therapeutic intervention.
Front Cell Dev Biol. 2024 May 17;12:1347126. doi: 10.3389/fcell.2024.1347126. eCollection 2024.
9
The In Vivo Chondrotoxicity of Single Intra-articular Injection of Local Anesthetic in Rat Cartilage.
Cureus. 2024 Jan 28;16(1):e53103. doi: 10.7759/cureus.53103. eCollection 2024 Jan.
10
The Efficacy of a Human-Ready mini Gene Therapy in a Pre-Clinical Model of Rett Syndrome.
Genes (Basel). 2023 Dec 24;15(1):31. doi: 10.3390/genes15010031.

本文引用的文献

1
Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics.
Regul Toxicol Pharmacol. 2017 Jun;86:221-230. doi: 10.1016/j.yrtph.2017.03.013. Epub 2017 Mar 16.
2
Evaluation of Intracameral Pentablock Copolymer Thermosensitive Gel for Sustained Drug Delivery to the Anterior Chamber of the Eye.
J Ocul Pharmacol Ther. 2017 Jun;33(5):353-360. doi: 10.1089/jop.2016.0181. Epub 2017 Mar 16.
5
Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma.
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4341-6. doi: 10.1167/iovs.16-19585.
6
Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs.
Mol Ther Methods Clin Dev. 2016 Jul 13;3:16046. doi: 10.1038/mtm.2016.46. eCollection 2016.
7
Advanced drug delivery and targeting technologies for the ocular diseases.
Bioimpacts. 2016;6(1):49-67. doi: 10.15171/bi.2016.07. Epub 2016 Mar 30.
8
Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles.
Int J Mol Sci. 2016 Jun 14;17(6):929. doi: 10.3390/ijms17060929.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验